Evidence map›Paper›PMID 29372325›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2019

Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI study.

A Uhlmann, B Bandelow, D J Stein, S Bloch, K R Engel, U Havemann-Reinecke, Dirk Wedekind

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

A UhlmannDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
B BandelowDepartment of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany.
D J SteinDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
S BlochDepartment of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany.
K R EngelDepartment of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany.
U Havemann-ReineckeDepartment of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany.
Dirk WedekindDepartment of Psychiatry and Psychotherapy, University Medical Centre, University of Goettingen, von-Siebold-Strasse 5, 37075, Göttingen, Germany. dirk.wedekind@med.uni-goettingen.de.
University of Göttingen · DEUniversity of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although depression and anxiety disorders are common comorbid conditions in alcohol dependence, few structural brain imaging studies have compared alcohol-dependent subjects with and without such comorbidity. In the current study, brain scans of 35 alcohol-dependent with and 40 individuals without diagnosis of a comorbid ICD-10 depressive or anxiety disorder receiving detoxification inpatient treatment were evaluated. Thickness and volumes of automatically segmented neuroanatomical structures were measured in FreeSurfer. Furthermore, associations of brain structure with biological markers and clinical severity markers of alcohol dependence were assessed. Despite comparable addiction severity, the non-comorbid group had evidence of higher cytotoxic effects of alcohol use on hepatic and haematological markers, and showed significantly smaller volumes of total cerebral, and cerebellar grey matter. Similarly, they showed unexpected smaller hippocampal and nucleus accumbens volumes, and thinner frontal, temporal and occipital cortices. Smaller brain volumes correlated with increased markers of hepatic and haematological dysfunction, and with longer duration of alcohol dependence in the non-comorbid group. Evidence of higher biomarkers of alcohol use may be indicative of more severe alcohol dependence or higher vulnerability to ethanol toxicity in this group. Furthermore, psychopathology-related drug treatment, which occurred in 53% of the comorbid group over the recent years, or tissue inflammation may have a moderate effect on the grade of cerebral atrophy in alcohol-dependent patients. Longitudinal studies are needed to investigate this issue more fully.

Indexed as

Anxiety DisordersDepressive DisorderAdultAgedAlcoholismBiomarkersCerebral CortexComorbidityErythrocyte IndicesFemalegamma-GlutamyltransferaseGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedBiomarkersgamma-Glutamyltransferasegamma-glutamyltransferase, humanAlcoholismCortexErythrocyte measuresLiver enzymesSubcortical volumes

Identifiers

PMID29372325
OpenAlexW2792351636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.